These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38113294)

  • 1. Steatotic liver disease in rural and regional Victoria, according to the NAFLD and newer diagnostic criteria: retrospective cohort analyses of 2001-03 and 2016-18 data.
    Vaz K; Kemp WW; Majeed A; Lubel J; Magliano D; Glenister K; Bourke L; Simmons D; Roberts SK
    Med J Aust; 2024 Feb; 220(2):97-99. PubMed ID: 38113294
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study.
    Roberts SK; Majeed A; Glenister K; Magliano D; Lubel JS; Bourke L; Simmons D; Kemp WW
    Med J Aust; 2021 Jul; 215(2):77-82. PubMed ID: 34028830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.
    Sanchez-Pareja A; Clément S; Peyrou M; Spahr L; Negro F; Rubbia-Brandt L; Foti M
    World J Gastroenterol; 2016 Apr; 22(14):3735-45. PubMed ID: 27076758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
    Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N
    J Hepatol; 2021 Aug; 75(2):284-291. PubMed ID: 33746083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
    Staufer K; Huber-Schönauer U; Strebinger G; Pimingstorfer P; Suesse S; Scherzer TM; Paulweber B; Ferenci P; Stimpfl T; Yegles M; Datz C; Trauner M
    J Hepatol; 2022 Oct; 77(4):918-930. PubMed ID: 35605744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.
    Kemp W; Clayton-Chubb D; Majeed A; Glenister KM; Magliano DJ; Lubel J; Bourke L; Simmons D; Roberts SK
    J Gastroenterol Hepatol; 2022 Feb; 37(2):395-403. PubMed ID: 34693553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
    Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS
    Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in epidemiology and serum markers for the noninvasive diagnosis of nonalcoholic fatty liver disease].
    Feng G; He N; Wang JN; Mi M; Niu CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):476-480. PubMed ID: 30317767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.
    Kummer S; Klee D; Kircheis G; Friedt M; Schaper J; Häussinger D; Mayatepek E; Meissner T
    Eur J Pediatr; 2017 Apr; 176(4):529-536. PubMed ID: 28213828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study.
    Wei F; Li J; Chen C; Zhang K; Cao L; Wang X; Ma J; Feng S; Li WD
    Front Endocrinol (Lausanne); 2020; 11():179. PubMed ID: 32328031
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study.
    Park JH; Hong JY; Kwon M; Lee J; Han K; Han IW; Kang W; Park JK
    Eur J Cancer; 2021 Jun; 150():73-82. PubMed ID: 33892409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
    Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
    Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
    Han AL
    BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting.
    Abd El-Wahab EW; Zein El-Abedin RA; Ahmed WM; Shatat HZ
    Am J Med Sci; 2020 Dec; 360(6):662-677. PubMed ID: 32739036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care.
    Bergram M; Nasr P; Iredahl F; Kechagias S; Rådholm K; Ekstedt M
    Scand J Gastroenterol; 2022 Jan; 57(1):60-69. PubMed ID: 34618619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD.
    Fukunaga S; Mukasa M; Nakano D; Tsutsumi T; Kawaguchi T
    Clin Mol Hepatol; 2024 Jan; 30(1):121-123. PubMed ID: 38044039
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction.
    Miller A; McNamara J; Hummel SL; Konerman MC; Tincopa MA
    Sci Rep; 2020 Jul; 10(1):12440. PubMed ID: 32709942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages-prospective study in Rajarata Pregnancy Cohort (RaPCo).
    Koralegedara IS; Warnasekara JN; Dayaratne KG; De Silva FN; Premadasa JK; Agampodi SB
    BMJ Open Gastroenterol; 2022 Feb; 9(1):. PubMed ID: 35193889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.